Methodological comparison of two anti-ZAP-70 antibodies
โ Scribed by Heba A. Degheidy; David J. Venzon; Mohammed Z. H. Farooqui; Fatima Abbasi; Diane C. Arthur; Wyndham H. Wilson; Adrian Wiestner; M. A. Stetler-Stevenson; Gerald E. Marti
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 517 KB
- Volume
- 80B
- Category
- Article
- ISSN
- 1552-4949
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract EBVโneutralizing antibody titers were determined in 11 sera derived from African Burkitt lymphoma or nasopharyngeal carcinoma patients and in the corresponding serum fractions retained above XM 100 Diaflo membranes after low pH treatment, and after recombination of the retained and pass
## Abstract ## Background: In this study we developed a method to measure the amount of ZAPโ70 [zeta accessory protein] in BโCLL cells without relying on the ZAPโ70 expression of patient B or T cells to normalize fluorescence intensity. ## Methods: BโCLL cells were fixed with formaldehyde before
## Abstract ## Background: Zetaโchain associated protein of 70kDa (ZAPโ70) is the most promising surrogate marker for the immunoglobulin heavy chain variable region (IgV~H~) mutation status in Bโcell chronic lymphocytic leukemia (BโCLL). Crespo et al. proposed the detection of ZAPโ70 by flow cytom